Log In
BCIQ
Print this Print this
 

Receptor activator of NF-kappa B ligand (RANKL) (TNFSF11)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Receptor activator of NF-kappa B ligand (RANKL) (TNFSF11)

BCIQ
Print ChartPrint this
1 - Musculoskeletal 1 - Cancer 1 - Musculoskeletal 1 - Autoimmune 1 - Cancer 1 - Endocrine / Metabolic 1 - Cancer 1 - Musculoskeletal 1 - Cancer 2 - Musculoskeletal 1 - Cancer
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistrationApprovedMarketed
Autoimmune

-

-

-

-

1

-

-

Cancer

1

1

1

1

-

-

1

Endocrine / Metabolic

-

-

1

-

-

-

-

Musculoskeletal

2

1

-

-

-

1

1




 Products Targeting Receptor activator of NF-kappa B ligand (RANKL) (TNFSF11)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$120.0M

$2.7M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today